This page is part of the FHIR Specification (v1.2.0: STU 3 Draft). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions
Definition for Value SetResponseToNeoadjuvantTherapy
{ "resourceType": "ValueSet", "id": "nehta-nehta-response-to-neoadjuvant-therapy", "meta": { "lastUpdated": "2015-12-11T16:38:40.294+10:00", "profile": [ "http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition" ] }, "text": { "status": "generated", "div": "<div>!-- Snipped for Brevity --></div>" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/valueset-oid", "valueUri": "urn:oid:2.16.840.1.113883.4.642.2.0" } ], "url": "http://hl7.org/fhir/ValueSet/nehta-nehta-response-to-neoadjuvant-therapy", "_url": { "fhir_comments": [ " DMc ?? SR says to make into a NEHTA oid ", "<extension url=\"http://hl7.org/fhir/StructureDefinition/valueset-oid\">\n <valueUri value=\"urn:oid:2.16.840.1.113883.3.88.12.80.67\"/> \n </extension>" ] }, "version": "20150625", "name": "ResponseToNeoadjuvantTherapy", "status": "draft", "experimental": true, "publisher": "HL7 (FHIR Project)", "contact": [ { "telecom": [ { "system": "other", "value": "http://hl7.org/fhir" }, { "system": "email", "value": "fhir@lists.hl7.org" } ] } ], "date": "2015-06-11T16:01:03+10:00", "description": "The response of the tumour to neoadjuvant treatment must be recorded.", "copyright": "This value set includes content from SNOMED CT, which is copyright © 2002+ International Health Terminology Standards Development Organisation (IHTSDO), and distributed by agreement between IHTSDO and HL7. Implementer use of SNOMED CT is not covered by this agreement", "codeSystem": { "fhir_comments": [ "<concept>\n <code value=\"grade_0_complete_response\"/>\n <display value=\"Grade 0 (complete response) No viable cancer cells\"/>\n <definition value=\"Grade 0 (complete response) No viable cancer cells\"/>\n </concept>\n <concept>\n <code value=\"grade_1_moderate_response\"/>\n <display value=\"Grade 1 (moderate response) Single cells or small groups of cancer cells\"/>\n <definition value=\"Grade 1 (moderate response) Single cells or small groups of cancer cells\"/>\n </concept>\n <concept>\n <code value=\"grade_2_minimal_response\"/>\n <display value=\"Grade 2 (minimal response) Residual cancer outgrown by fibrosis\"/>\n <definition value=\"Grade 2 (minimal response) Residual cancer outgrown by fibrosis\"/>\n </concept>\n <concept>\n <code value=\"grade_3_poor_response\"/>\n <display value=\"Grade 3 (poor response) Minimal or no tumour kill; extensive residual cancer.\"/>\n <definition value=\"Grade 3 (poor response) Minimal or no tumour kill; extensive residual cancer.\"/>\n </concept>" ], "system": "http://hl7.org/fhir/nehta-response-to-neoadjuvant-therapy", "_system": { "fhir_comments": [ " These result values are from \n Ryan R, Gibbons D and Hyland JMP (2005). Pathological response following long-course neoadjuvant \n chemoradiotherapy for locally advanced rectal cancer. Histopathology(47):141-146. ", " DMc ?? SR says to make into a NEHTA oid ", "<extension url=\"http://hl7.org/fhir/StructureDefinition/valueset-oid\">\n <valueUri value=\"urn:oid:2.16.840.1.113883.3.88.12.80.67\"/> \n </extension>" ] }, "version": "20150625", "caseSensitive": true, "concept": [ { "code": "no_prior_treatment", "display": "No prior treatment", "definition": "No prior treatment" } ] }, "compose": { "include": [ { "system": "http://snomed.info/sct", "concept": [ { "code": "444431007", "display": "Grade 0 on a scale of 0 to 3 (qualifier value)" }, { "code": "444456001", "display": "Grade 1 on a scale of 0 to 3 (qualifier value)" }, { "code": "444457005", "display": "Grade 2 on a scale of 0 to 3 (qualifier value)" }, { "code": "444447009", "display": "Grade 3 on a scale of 0 to 3 (qualifier value)" } ] } ] } }
Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.